179 related articles for article (PubMed ID: 34913022)
1. Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.
Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Zhu Z; Wang X; Etxart A; Park Y; Bujanda L; Park IJ; Goel A
JCO Precis Oncol; 2021; 5():. PubMed ID: 34913022
[TBL] [Abstract][Full Text] [Related]
2. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.
Cho E; Park IJ; Yeom SS; Hong SM; Lee JB; Kim YW; Kim MJ; Lim HM; Lim SB; Yu CS; Kim JC
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):834-842. PubMed ID: 31419511
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
[TBL] [Abstract][Full Text] [Related]
4. Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.
Millino C; Maretto I; Pacchioni B; Digito M; De Paoli A; Canzonieri V; D'Angelo E; Agostini M; Rizzolio F; Giordano A; Barina A; Rajendran S; Esposito G; Lanfranchi G; Nitti D; Pucciarelli S
J Cell Physiol; 2017 Feb; 232(2):426-435. PubMed ID: 27225591
[TBL] [Abstract][Full Text] [Related]
5. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
[TBL] [Abstract][Full Text] [Related]
6. A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
Park IJ; Yu YS; Mustafa B; Park JY; Seo YB; Kim GD; Kim J; Kim CM; Noh HD; Hong SM; Kim YW; Kim MJ; Ansari AA; Buonaguro L; Ahn SM; Yu CS
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32225122
[TBL] [Abstract][Full Text] [Related]
7. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
[TBL] [Abstract][Full Text] [Related]
8. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.
D'Angelo E; Zanon C; Sensi F; Digito M; Rugge M; Fassan M; Scarpa M; Pucciarelli S; Nitti D; Agostini M
J Clin Pathol; 2018 Apr; 71(4):344-350. PubMed ID: 28870889
[TBL] [Abstract][Full Text] [Related]
9. A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer.
Xiao WW; Li M; Guo ZW; Zhang R; Xi SY; Zhang XG; Li Y; Wu DQ; Ren YF; Pang XL; Wan XB; Li K; Zhou CL; Zhai XM; Liang ZK; Wang QX; Zeng ZF; Zhang HZ; Yang XX; Wu YS; Li M; Gao YH
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):482-491. PubMed ID: 33434612
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
[TBL] [Abstract][Full Text] [Related]
12. Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy.
Bedin C; Crotti S; D'Angelo E; D'Aronco S; Pucciarelli S; Agostini M
Curr Med Chem; 2020; 27(25):4274-4294. PubMed ID: 31060482
[TBL] [Abstract][Full Text] [Related]
13. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
[TBL] [Abstract][Full Text] [Related]
14. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
[TBL] [Abstract][Full Text] [Related]
16. Validation of the standardized index of shape tool to analyze DCE-MRI data in the assessment of neo-adjuvant therapy in locally advanced rectal cancer.
Fusco R; Granata V; Sansone M; Rega D; Delrio P; Tatangelo F; Romano C; Avallone A; Pupo D; Giordano M; Grassi R; Ravo V; Pecori B; Petrillo A
Radiol Med; 2021 Aug; 126(8):1044-1054. PubMed ID: 34041663
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response.
Canto LMD; Cury SS; Barros-Filho MC; Kupper BEC; Begnami MDFS; Scapulatempo-Neto C; Carvalho RF; Marchi FA; Olsen DA; Madsen JS; Havelund BM; Aguiar S; Rogatto SR
Sci Rep; 2019 Jun; 9(1):8702. PubMed ID: 31213644
[TBL] [Abstract][Full Text] [Related]
18. Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.
Ferrando L; Cirmena G; Garuti A; Scabini S; Grillo F; Mastracci L; Isnaldi E; Marrone C; Gonella R; Murialdo R; Fiocca R; Romairone E; Ballestrero A; Zoppoli G
PLoS One; 2020; 15(2):e0226595. PubMed ID: 32023246
[TBL] [Abstract][Full Text] [Related]
19. Improvement in the Assessment of Response to Preoperative Chemoradiotherapy for Rectal Cancer Using Magnetic Resonance Imaging and a Multigene Biomarker.
Cho E; Jung SW; Park IJ; Jang JK; Park SH; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298695
[TBL] [Abstract][Full Text] [Related]
20. miR-519b-3p promotes responsiveness to preoperative chemoradiotherapy in rectal cancer patients by targeting ARID4B.
Luo J; Liu L; Zhou N; Shen J; Sun Q; Zhu Y; Chen M
Gene; 2018 May; 655():84-90. PubMed ID: 29477868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]